BAYN.DE vs. MRNA
Compare and contrast key facts about Bayer Aktiengesellschaft (BAYN.DE) and Moderna, Inc. (MRNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BAYN.DE or MRNA.
Key characteristics
| BAYN.DE | MRNA | |
|---|---|---|
| YTD Return | -19.45% | -31.34% |
| 1Y Return | -44.60% | -39.47% |
| 3Y Return (Ann) | -13.77% | -45.84% |
| 5Y Return (Ann) | -14.01% | 32.57% |
| Sharpe Ratio | -1.31 | -0.62 |
| Daily Std Dev | 34.01% | 60.35% |
| Max Drawdown | -81.09% | -85.91% |
| Current Drawdown | -74.77% | -85.91% |
Fundamentals
| BAYN.DE | MRNA | |
|---|---|---|
| Market Cap | €26.51B | $26.25B |
| EPS | -€1.29 | -$15.35 |
| PEG Ratio | 36.69 | 0.00 |
| Total Revenue (TTM) | €47.11B | $5.05B |
| Gross Profit (TTM) | €27.36B | $1.59B |
| EBITDA (TTM) | €11.71B | -$4.02B |
Correlation
The correlation between BAYN.DE and MRNA is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BAYN.DE vs. MRNA - Performance Comparison
In the year-to-date period, BAYN.DE achieves a -19.45% return, which is significantly higher than MRNA's -31.34% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BAYN.DE vs. MRNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bayer Aktiengesellschaft (BAYN.DE) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BAYN.DE vs. MRNA - Dividend Comparison
BAYN.DE's dividend yield for the trailing twelve months is around 0.41%, while MRNA has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAYN.DE Bayer Aktiengesellschaft | 0.41% | 7.14% | 4.14% | 4.26% | 5.81% | 3.85% | 2.81% | 1.95% | 1.56% | 1.20% | 1.15% | 1.15% |
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BAYN.DE vs. MRNA - Drawdown Comparison
The maximum BAYN.DE drawdown since its inception was -81.09%, smaller than the maximum MRNA drawdown of -85.91%. Use the drawdown chart below to compare losses from any high point for BAYN.DE and MRNA. For additional features, visit the drawdowns tool.
Volatility
BAYN.DE vs. MRNA - Volatility Comparison
The current volatility for Bayer Aktiengesellschaft (BAYN.DE) is 13.06%, while Moderna, Inc. (MRNA) has a volatility of 18.09%. This indicates that BAYN.DE experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BAYN.DE vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between Bayer Aktiengesellschaft and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities